MedPath

Investigation of Cigarette Cravings in Smokers

Not Applicable
Conditions
Tobacco Use
Addiction Nicotine
Cigarette Smoking
Interventions
Behavioral: Stress induction
Behavioral: Control stress exposure
Behavioral: Cue induction
Behavioral: Neutral cue exposure
Registration Number
NCT04843969
Lead Sponsor
Marco Leyton
Brief Summary

Interventions to disrupt memory reconsolidation have held promise for the treatment of stress- and anxiety-related disorders. In the present study, the investigators will examine whether an intervention based on these principles, called memory updating, could be adapted for reward-seeking behaviors. To test this, non-treatment seeking tobacco smokers will be exposed to smoking cues and/or stress, two stimuli known to trigger smoking. It is predicted that exposure to a stress task will enhance the cues' motivational salience and yield greater susceptibility to the memory updating procedure.

As an add-on, the investigators will examine COVID-associated changes in substance use and whether participants in the memory updating groups might be more resilient to these effects. It is predicted that the changes in substance use will depend on whether the substances are used primarily in social settings.

Detailed Description

Non-treatment seeking cigarette dependent smokers will be randomized to one of four testing conditions: 1) a non-stressful task followed by neutral cues, 2) the non-stressful task followed by smoking cues, 3) a stressful task followed by neutral cues, or 4) the stressful task followed by smoking cues. Ten minutes after the intervention, participants will undergo a 60-minute extinction procedure consisting of smoking-related videos, images and smoking paraphernalia. Cue reactivity test sessions will take place 24 hours, 2 weeks and 6 weeks following the intervention.

COVID-associated changes in substance use will be quantified over three telephone interviews: one at the end of March / beginning of April 2020 (at the start of the pandemic), one at the end of April / beginning of May, and a final one which will be instituted if feasible once the infection rates and social distancing policies have decreased.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
76
Inclusion Criteria
  • Scoring 5 or higher on the Fagerström Test for Cigarette Dependence
  • Willingness to abstain from smoking for 4 hours prior to each laboratory visit
Exclusion Criteria
  • Currently using cigarette cessation products
  • Endocrinological problems
  • Significant mental or physical health conditions
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Stress task and smoking cueStress inductionExposure to a psychosocial stress task followed by smoking video cues
Stress task and smoking cueCue inductionExposure to a psychosocial stress task followed by smoking video cues
Control task and neutral cueNeutral cue exposureExposure to a control task followed by neutral video cues
Stress task and neutral cueStress inductionExposure to a psychosocial stress task followed by neutral video cues
Control task and smoking cueCue inductionExposure to a control task followed by smoking video cues
Control task and neutral cueControl stress exposureExposure to a control task followed by neutral video cues
Stress task and neutral cueNeutral cue exposureExposure to a psychosocial stress task followed by neutral video cues
Control task and smoking cueControl stress exposureExposure to a control task followed by smoking video cues
Primary Outcome Measures
NameTimeMethod
Change in cigarettes smoked per day from the pre-intervention baseline to test sessions 2 and 3 given two and six weeks post-interventionAt the end of test session 1 (24 hours post-intervention), participants will receive a journal to record their daily smoking behaviour. They are asked to keep this journal until test session 3 (6 weeks post-intervention).

A journal is given to participants to record their cigarette use behaviour every day for a month and a half

Secondary Outcome Measures
NameTimeMethod
Change in smoking cue-induced cigarette cravings from the pre-intervention baseline to test session 2Multiple times points during the baseline, intervention and test sessions at 24 hours, 2 weeks and 6 weeks post-intervention.

Participants will be asked to complete craving and urge to smoke questionnaires at several time points throughout the study sessions

Change in smoking cue-induced cigarette cravings from the pre-intervention baseline to test session 3Multiple times points during the baseline, intervention and test sessions at 24 hours, 2 weeks and 6 weeks post-intervention.

Participants will be asked to complete craving and urge to smoke questionnaires at several time points throughout the study sessions

Change in smoking cue-induced heart rate responses from the pre-intervention baseline to test session 2Multiple time points during the baseline, intervention and test sessions at 24 hours, 2 weeks and 6 weeks post-intervention

Participants' heart rate will be measured through the use of a polar belt at several time points during the study sessions

Change in smoking cue-induced heart rate responses from the pre-intervention baseline to test session 3Multiple time points during the baseline, intervention and test sessions at 24 hours, 2 weeks and 6 weeks post-intervention

Participants' heart rate will be measured through the use of a polar belt at several time points during the study sessions

Change in smoking cue-induced skin conductance responses from the pre-intervention baseline to test session 2Multiple time points during the baseline, intervention and test sessions at 24 hours, 2 weeks and 6 weeks post-intervention

Participants' skin conductance will be measured through the use of electrodes on their index and middle fingers at several time points during the study sessions

Change in smoking cue-induced skin conductance responses from the pre-intervention baseline to test session 3Multiple time points during the baseline, intervention and test sessions at 24 hours, 2 weeks and 6 weeks post-intervention

Participants' skin conductance will be measured through the use of electrodes on their index and middle fingers at several time points during the study sessions

Change in tobacco and other substance use patterns from the pre-COVID-19 baseline to during COVID-19Multiple time points at baseline (before the pandemic), at the start of the pandemic, and during the pandemic

Participants will be asked to report the quantity of cigarettes and/or other substances they have consumed recently

Change in tobacco and other substance use patterns from the pre-COVID-19 baseline to post-COVID-19At baseline (before the pandemic) and through study completion, an average of 1 year

Participants will be asked to report the quantity of cigarettes and/or other substances they have consumed recently

Change in tobacco and other substance use patterns during the COVID-19 pandemic to post-COVID-19Multiple time points during the pandemic and through study completion, an average of 1 year

Participants will be asked to report the quantity of cigarettes and/or other substances they have consumed recently

Trial Locations

Locations (1)

McGill University

🇨🇦

Montreal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath